These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 26680092
1. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. Åberg F, Abdulle A, Mäkelä A, Nissinen M. Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092 [Abstract] [Full Text] [Related]
2. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Mouchli MA, Singh S, Boardman L, Bruining DH, Lightner AL, Rosen CB, Heimbach JK, Hasan B, Poterucha JJ, Watt KD, Kane SV, Raffals LE, Loftus EV. Inflamm Bowel Dis; 2018 Apr 23; 24(5):1074-1081. PubMed ID: 29522202 [Abstract] [Full Text] [Related]
3. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series. Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, Chazouilleres O, Duvoux C, Dumortier J, Leroy V, Treton X, Durand F, Dharancy S, Nachury M, Goutorbe F, Lamblin G, Boivineau L, Peyrin-Biroulet L, Pageaux GP. Dig Liver Dis; 2018 Jul 23; 50(7):668-674. PubMed ID: 29655972 [Abstract] [Full Text] [Related]
5. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF. Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898 [Abstract] [Full Text] [Related]
6. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM. Clin Gastroenterol Hepatol; 2013 May 27; 11(5):517-23. PubMed ID: 23333218 [Abstract] [Full Text] [Related]
7. Inflammatory bowel disease in liver transplanted patients. Filipec Kanizaj T, Mijic M. World J Gastroenterol; 2017 May 14; 23(18):3214-3227. PubMed ID: 28566881 [Abstract] [Full Text] [Related]
8. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Jørgensen KK, Grzyb K, Lundin KE, Clausen OP, Aamodt G, Schrumpf E, Vatn MH, Boberg KM. Inflamm Bowel Dis; 2012 Mar 14; 18(3):536-45. PubMed ID: 21456044 [Abstract] [Full Text] [Related]
9. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes. Peverelle M, Paleri S, Hughes J, De Cruz P, Gow PJ. Inflamm Bowel Dis; 2020 Nov 19; 26(12):1901-1908. PubMed ID: 31944235 [Abstract] [Full Text] [Related]
10. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis. Singh S, Edakkanambeth Varayil J, Loftus EV, Talwalkar JA. Liver Transpl; 2013 Dec 19; 19(12):1361-9. PubMed ID: 24019127 [Abstract] [Full Text] [Related]
11. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J. Clin Gastroenterol Hepatol; 2018 Jul 19; 16(7):1106-1113.e3. PubMed ID: 29378311 [Abstract] [Full Text] [Related]
12. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. de Vries AB, Janse M, Blokzijl H, Weersma RK. World J Gastroenterol; 2015 Feb 14; 21(6):1956-71. PubMed ID: 25684965 [Abstract] [Full Text] [Related]
13. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Ricciuto A, Fish J, Carman N, Walters TD, Church PC, Hansen BE, Crowley E, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM. Clin Gastroenterol Hepatol; 2018 Jul 14; 16(7):1098-1105.e1. PubMed ID: 29378308 [Abstract] [Full Text] [Related]
14. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis. Hanouneh IA, Macaron C, Lopez R, Zein NN, Lashner BA. Inflamm Bowel Dis; 2012 Feb 14; 18(2):269-74. PubMed ID: 21425212 [Abstract] [Full Text] [Related]
15. Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Rao BB, Lashner B, Kowdley KV. Inflamm Bowel Dis; 2018 Jan 18; 24(2):269-276. PubMed ID: 29361103 [Abstract] [Full Text] [Related]
16. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz SH. Gut Liver; 2018 Jan 15; 12(1):17-29. PubMed ID: 28376583 [Abstract] [Full Text] [Related]
17. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Broomé U, Löfberg R, Lundqvist K, Veress B. Dis Colon Rectum; 1995 Dec 15; 38(12):1301-5. PubMed ID: 7497843 [Abstract] [Full Text] [Related]